These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

228 related items for PubMed ID: 23233437

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Development of novel tetrahydrothieno[2,3-c]pyridine-3-carboxamide based Mycobacterium tuberculosis pantothenate synthetase inhibitors: molecular hybridization from known antimycobacterial leads.
    Samala G, Devi PB, Nallangi R, Sridevi JP, Saxena S, Yogeeswari P, Sriram D.
    Bioorg Med Chem; 2014 Mar 15; 22(6):1938-47. PubMed ID: 24565972
    [Abstract] [Full Text] [Related]

  • 5. Identification and development of 2-methylimidazo[1,2-a]pyridine-3-carboxamides as Mycobacterium tuberculosis pantothenate synthetase inhibitors.
    Samala G, Nallangi R, Devi PB, Saxena S, Yadav R, Sridevi JP, Yogeeswari P, Sriram D.
    Bioorg Med Chem; 2014 Aug 01; 22(15):4223-32. PubMed ID: 24953948
    [Abstract] [Full Text] [Related]

  • 6. Structural insight into Mycobacterium tuberculosis maltosyl transferase inhibitors: pharmacophore-based virtual screening, docking, and molecular dynamics simulations.
    Sengupta S, Roy D, Bandyopadhyay S.
    J Biomol Struct Dyn; 2015 Aug 01; 33(12):2655-66. PubMed ID: 25669125
    [Abstract] [Full Text] [Related]

  • 7. Cross-docking study on InhA inhibitors: a combination of Autodock Vina and PM6-DH2 simulations to retrieve bio-active conformations.
    Stigliani JL, Bernardes-Génisson V, Bernadou J, Pratviel G.
    Org Biomol Chem; 2012 Aug 21; 10(31):6341-9. PubMed ID: 22751934
    [Abstract] [Full Text] [Related]

  • 8. Shape-based virtual screening, docking, and molecular dynamics simulations to identify Mtb-ASADH inhibitors.
    Kumar R, Garg P, Bharatam PV.
    J Biomol Struct Dyn; 2015 Aug 21; 33(5):1082-93. PubMed ID: 24875451
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Structure-guided design of thiazolidine derivatives as Mycobacterium tuberculosis pantothenate synthetase inhibitors.
    Devi PB, Samala G, Sridevi JP, Saxena S, Alvala M, Salina EG, Sriram D, Yogeeswari P.
    ChemMedChem; 2014 Nov 21; 9(11):2538-47. PubMed ID: 25155986
    [Abstract] [Full Text] [Related]

  • 11. Design of Novel Mycobacterium tuberculosis Pantothenate Synthetase Inhibitors: Virtual Screening, Synthesis and In Vitro Biological Activities.
    Devi PB, Jogula S, Reddy AP, Saxena S, Sridevi JP, Sriram D, Yogeeswari P.
    Mol Inform; 2015 Feb 21; 34(2-3):147-59. PubMed ID: 27490037
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Structure-based design of diverse inhibitors of Mycobacterium tuberculosis N-acetylglucosamine-1-phosphate uridyltransferase: combined molecular docking, dynamic simulation, and biological activity.
    Soni V, Suryadevara P, Sriram D, OSDD Consortium, Kumar S, Nandicoori VK, Yogeeswari P.
    J Mol Model; 2015 Jul 21; 21(7):174. PubMed ID: 26078037
    [Abstract] [Full Text] [Related]

  • 16. A comparative modeling and molecular docking study on Mycobacterium tuberculosis targets involved in peptidoglycan biosynthesis.
    Fakhar Z, Naiker S, Alves CN, Govender T, Maguire GE, Lameira J, Lamichhane G, Kruger HG, Honarparvar B.
    J Biomol Struct Dyn; 2016 Nov 21; 34(11):2399-417. PubMed ID: 26612108
    [Abstract] [Full Text] [Related]

  • 17. Comparative modeling and dynamic simulation of UDP-N-acetylmuramoyl-alanine ligase (MurC) from Mycobacterium tuberculosis through virtual screening and toxicity analysis.
    Isa MA.
    Life Sci; 2020 Dec 01; 262():118466. PubMed ID: 32961233
    [Abstract] [Full Text] [Related]

  • 18. Ligand based virtual screening and biological evaluation of inhibitors of chorismate mutase (Rv1885c) from Mycobacterium tuberculosis H37Rv.
    Agrawal H, Kumar A, Bal NC, Siddiqi MI, Arora A.
    Bioorg Med Chem Lett; 2007 Jun 01; 17(11):3053-8. PubMed ID: 17418569
    [Abstract] [Full Text] [Related]

  • 19. Discovery of novel inhibitors of Mycobacterium tuberculosis MurG: homology modelling, structure based pharmacophore, molecular docking, and molecular dynamics simulations.
    Saxena S, Abdullah M, Sriram D, Guruprasad L.
    J Biomol Struct Dyn; 2018 Sep 01; 36(12):3184-3198. PubMed ID: 28948866
    [Abstract] [Full Text] [Related]

  • 20. Quantum mechanics/molecular mechanics strategies for docking pose refinement: distinguishing between binders and decoys in cytochrome C peroxidase.
    Burger SK, Thompson DC, Ayers PW.
    J Chem Inf Model; 2011 Jan 24; 51(1):93-101. PubMed ID: 21133348
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.